Back to the main directory
EarningsReview / Equity
- Peab (Buy, TP: SEK100.00) - Mixed Q3, but new targets coming by DnB Markets
- Essity (Hold, TP: SEK295.00) - New structural programmes ahead by DnB Markets
- DNB (No_rec, TP: NOK) - Capital buffers at historical high by DnB Markets
- SSAB (Buy, TP: SEK35.00) - Positive revisions still on the table by DnB Markets
- Kone (Hold, TP: EUR73.00) - Q3 in line; on course for a strong Q4 by DnB Markets
- Atlas Copco (Sell, TP: SEK340.00) - Strong performance from CT by DnB Markets
- Good times ahead by DnB Markets
- Itaú BBA on Walmex: 3Q20 Results in Line with Expectations by Itau
- Itaú BBA on Vesta: Overall Positive 3Q20 Results by Itau
- AAK - When ‘cautiously optimistic’ is good enough by Danske Bank Equity Research
- Essity - No reason for the doom-and-gloom valuation by Danske Bank Equity Research
- AAK - Buy/SEK 200: Q3 demonstrated that the worst is behind us by Nordea
- Atlas Copco - Hold: Solid report but question marks about the recovery by Nordea
- BillerudKorsnaes - Hold: Struggling to see material upside by Nordea
- DNB - Hold: Struggling with low rates and payout uncertainty by Nordea
- Huhtamaki - Hold: Demand in food-service sector could stay volatile by Nordea
- Mycronic - Great quarter for PG, and another one, and another… by Danske Bank Equity Research
- Nordic Entertainment Group - Hold: Exciting potential but currently at fair value by Nordea
- Swedish Orphan Biovitrum - Buy/SEK 265: Solid Q3 but lack of triggers in the near term by Nordea
- Volati - Buy/SEK 90 (85): Under the hood, all good by Nordea
- Q320 postview (+15 questions for management) by BNP Paribas Exane
- Alma Media - Buy/EUR 8.70 (8.50): 2020 earnings outlook materially above consensus by Nordea
- SEB - Buy/SEK 98: Solid report shadowed by AML concerns by Nordea
- Q3''20 postview. Covid hangover to last into 2021 by BNP Paribas Exane
- Why are we even surprised? by BNP Paribas Exane